Mira Pharmaceuticals Inc expected to post a loss of 13 cents a share - Earnings Preview

Mira Pharmaceuticals

11/08/2025 21:13

Mira Pharmaceuticals Inc MIRA.OQ MIRA.O is expected to  show no change in quarterly revenue when it reports  results on August 13 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Mira Pharmaceuticals Inc is for a loss of 13 cents per share.

The one available analyst rating on the shares is "hold".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Mira Pharmaceuticals Inc is $17.75, about 92.2% above its last closing price of $1.38

This summary was machine generated August 11 at 20:13 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)